Management of Cardiac Amyloidosis
February 19, 2026
Target Audience
All pharmacists
Learning Objectives
At the completion of this activity, the participant will be able to:
Define cardiac amyloidosis and its major clinical subtypes
Identify risk factors and clinical features that raise suspicion for cardiac amyloidosis
Discuss pharmacological and non-pharmacological treatment options for cardiac amyloidosis
State literature supporting disease-modifying therapies of cardiac amyloidosis
ZOOM or Brooklyn Hospital
United States
Anisha Varghese PharmD
PGY2 Ambulatory Care Resident
The Brooklyn Hospital Center
ACPE UAN 0042-0000-26-005-L01-P
Available Credit
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Facebook
X
LinkedIn
Forward